Welcome back to “The Nematode Corner,” where we continue our journey into the extraordinary world of Caenorhabditis elegans (C. elegans). […]
The Nematode Corner: Unearthing Nutraceutical Discoveries Read Post »
Contract research organisation Magnitude Biosciences is projecting significant growth as it looks to tap into the multi-billion-pound nutraceutical and pharmaceutical
Magnitude Biosciences: Revolutionising Research Read Post »
Welcome to the fascinating world of C. elegans, a microscopic nematode worm that holds the key to unlocking groundbreaking insights
The Nematode Corner: Powering Industry Progress Read Post »
Publication: New tools to monitor Pseudomonas aeruginosa infection and biofilms in vivo in C. elegans
Press Release: 24th July 2023 Newcastle based Life Sciences and Biomedical businesses, LightOx, NunaBio, Magnitude Biosciences and Hexis Lab are
May 2023, Sedgefield, United Kingdom Photo: The Magnitude Biosciences Team Magnitude Biosciences Limited, a specialist provider of C. elegans research
Magnitude Biosciences partnered with AB Biotek Human Nutrition & Health (ABB HNH), the global leader in yeast probiotics and postbiotics.
AB Biotek works with Magnitude Biosciences to accelerate probiotic development Read Post »
We help our partners in the nutraceuticals & ingredients industry uncover and validate the diverse health benefits of their compounds.
David Weinkove, CEO of Magnitude Biosciences joins New Matter
Podcast: ‘Tiny Worms, Experiments Fast’ on New Matter Read Post »
Michelin, a Fortune 500 consumer good manufacturing company and the global leader in tyre manufacturing, works with Magnitude Biosciences for a sustainable, ethical solution for whole organism toxicity testing.
Case Study: Michelin & Magnitude Biosciences Read Post »
